Amsterdam, The Netherlands

Slides:



Advertisements
Similar presentations
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Advertisements

HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines Treatment Recommendations for Pregnant and Breastfeeding Women: Critical Issues Dr. Nathan Shaffer.
Towards Universal Access Recommendations for a Public Health Approach BASED ON WHO GUIDELINES Antiretroviral Drugs for Treating Pregnant Women and Preventing.
Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA,
Weighing 17 years of evidence: Does hormonal contraception increase HIV acquisition risk among Zambian women in discordant couples? Kristin.
11 HIV and contraception – complex issues for safe choice: the latest recommendations from the World Health Organization (WHO) Mary Lyn Gaffield, Sharon.
Translating Research to Practice: Community Based Distribution (CBD) of DepoProvera (DMPA) in Kenya Alice Olawo 1, Jane Gitonga 2, Elizabeth Washika 3.
Susan Adamchak, Heidi Reynolds, Barbara Janowitz, Thomas Grey, Emily Keyes October 21, 2008 FP and HIV/AIDS Integration: Findings from 5 Countries.
Child and Adolescent Health and Development RHR RHR Guidance of WHO on safe abortion FIAPAC, Moscow October 28, 2005 G. Lazdane Regional Adviser RHR WHO.
Credentials Committee Orientation. Responsibilities of the Committee Review the credentials of all applicants to the Medical Staff and privileges requests.
Scaling-up male circumcision programmes in the Eastern and Southern Africa region Country Update Meeting June 2010 Dr Sibongile Dludlu UNAIDS RST/ESA.
ACCESS TO AND USE OF FAMILY PLANNING BY WOMEN WITH HIV IAS, Cape Town IAS, Cape Town Revisiting Contraception and HIV Bridging Session 22 nd July 2009.
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
Effectiveness of Contraception for HIV-Infected Women using Antiretroviral Therapy Maria Pyra a,b, Renee Heffron a,b, Nelly R. Mugo b,d,e,
Washington D.C., USA, July 2012www.aids2012.org Sources of HIV Epidemiological Data for Monitoring and Estimating the burden of HIV Txema Calleja,
Contraceptive Options for Women and Couples with HIV.
It is uncertain whether male circumcision (MC) reduces the risk of syphilis among men and women Partners PrEP Study data (n=4,716) analyzed to assess association.
Eastern European Alliance for Reproductive Choice REPRODUCTIVE CHOICE FOR HIV- INFECTED WOMEN Prof. POSOKHOVA S.P. UKRAINE УКРАЇНАУКРАЇНА.
July 2015 Core Epidemiology Slides.
Adesina OA*, Awolude O, Oladokun A, Roberts A, Adewole IF, Department of Obstetrics & Gynaecology, College of Medicine, University of Ibadan. *Corresponding.
Washington D.C., USA, July 2012www.aids2012.org Sexual & Reproductive Health & Rights of Women living with HIV
The Impact of HIV on a Future NHI
Acquisition of STIs among Women Using a Variety of Contraceptive Options: A Prospective Study among High-Risk African Women Flavia Matovu Kiweewa, Elizabeth.
Meg Rosenberg, M.D., Montefiore School Health Program
New National Family Planning Guidelines for Service Providers
Demanding a high impact HIV response: civil society advocacy and the President’s Emergency Plan for Aids Relief (PEPFAR) Dorothy Namutamba International.
Aminatou Sar, seconaf, rhsc wednesday, february 1, 2017
Operations Research Mini-Course University of Washington ______________________________________ Qualitative Methods in Implementation Science ____________________________________________.
Module 4 (e) Pregnancy and Breast Feeding
MagGie Murphy, John Snow, Inc. (JSI) wednesday, february 1, 2017
New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications WHO/UNAIDS Technical Consultation on Male Circumcision and HIV.
Purpose and Process of WHO guideline development
Michael Lowe, PhD, MSPH Division of Reproductive Health
Financing for the long haul: Elimination of Epidemics of AIDS and Viral Hepatitis Alan Whiteside OBE Chair in Global Health Policy, Balsillie School of.
How does teamwork improve value. Dr Nils E
Nurses at the Forefront: The Key to Achieving
Global epidemiology of injecting drug use
Healthcare Strategies for HIV-Positive Girls and Women: Can We Do Better?
Stop TB Partnership Secretariat (TBP)
CTU – Health HSS110 Final Presentation
Dr Evelyn Kortum, WHO Geneva
WHO Guideline development
The Impact of HIV on a Future NHI
Setting the Stage for PrEP Where are we now, and where should we go?
Finding the right target population for PrEP The cost-effectiveness of PrEP provision to adolescents and young women in South Africa Gesine Meyer-Rath1,2,
Dr Evelyn Kortum, WHO Geneva
Jepkoech Kottutt1, Emilia D. Rivadeneira2, Susan Hrapcak2
Implementation of WHO MEC recommendations
Accelerating the response for children affected by AIDS
What does the new WHO guideline on hormonal contraceptive say ?
PrEP.
Global Optimization of the Response to HIV
Ageism, Aging and HIV: A Call to Action
WHO’s Family Planning Guidance Documents and Job Aids
Operations Research Mini-Course University of Washington ______________________________________ Qualitative Methods in Implementation Science ____________________________________________.
TB Strategy & Health Systems (TBS) TB Monitoring & Evaluation (TME)
Building the Community Response to the Dolutegravir Safety Signal
MEDICAL ELIGIBILITY CRITERIA
Division of AIDS Office of the Director Workforce Operations,
Progress on Voluntary Medical Male Circumcision for HIV prevention and How VMMC fits into UNAIDS ' ' target Julia Samuelson, Nurse epidemiologist.
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial
Core epidemiology slides
July 2018 Core epidemiology slides.
Mexico City, Mexico, July 21st 2019
Contraception and HIV: update on the evidence and implications for programmes Symposium: Sexual and reproductive health and HIV prevention Jared Baeten.
Contraceptive Hormone Induced Changes - CHIC
Petrus Steyn and James Kiarie
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Amsterdam, The Netherlands AIDS 2018 Amsterdam, The Netherlands 27 July 2018 07:00 – 08:30 Venue: Elicium 1 From research to policy to practice: WHO medical eligibility criteria (MEC) for progestogen only contraception use by women at high risk of HIV infection Co-Chairs James Kiarie, WHO RHR Petrus Steyn, WHO RHR Speakers James Kiarie, WHO Human Reproduction Team, Development of WHO MEC guidelines Renee Heffron, Departments of Global Health and Epidemiology, International Clinical Research Center, University of Washington, USA Differences in DMPA-IM, DMPA-SC and NET-EN relative to the potential impact on HIV acquisition in women Petrus Steyn, WHO Human Reproduction Team Implementation of WHO MEC recommendations Lillian Mworeko, International Community of women living with HIV Eastern Africa (ICWEA), Uganda What should the advocacy agenda for the process of guidance be? Photo: Arturo Sanabria, Photoshare For further details: Dr Petrus Steyn: steynp@who.int http://programme.aids2018.org/Programme/Session/1464